Page 20 - Bharat Biotech

Bharat Biotech, SII seek to use Covid jab on those using blood thinners

"Both the companies have written to the DCGI regarding changing this point and that will happen very soon," Bhargava said

British firm GSK to move malaria vaccine production to Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the malaria vaccine

Bharat Biotech's Covaxin effective against Covid-19 UK strain: ICMR

The genome of the UK-variant has 17 mutations, eight of those were in the spike protein domain

GSK transfers malaria vaccine production to India's Bharat Biotech

The agreement includes transfer of manufacturing of the protein part of the vaccine

Bharat Biotech's Covaxin effective on UK strain of Covid-19: ICMR

In phase II clinical trial, the vaccine candidate showed noteworthy results with plaque reduction neutralization test

BS Reads: From deal-making to air lifting, how the world will be vaccinated

While mass airlifting of vaccines is yet to begin, global deal-making shows many interesting trends

Bharat Biotech's Covaxin has tolerable safety, says Lancet study

Sharing the interim findings, the paper said that the vaccine was well tolerated in all dose groups with no vaccine-related adverse events

No politics, followed scientific advice on Covid-19 vaccine, says PM Modi

In an interaction with beneficiaries from his constituency, PM assures both vaccines safe

13,000 volunteers given 2nd Covaxin dose in phase-3 trials: Bharat Biotech

Covaxin has received emergency use approval from India's drug regulator on a 'clinical trial mode'

Bharat Biotech first Indian Covid vaccine maker to get peer-reviewed data

There were no serious side effects in the participants enrolled for the phase 1 trials, according to the results published in The Lancet

UK, Belgium among nations seeking cheaper India-made coronavirus vaccines

Serum, the world's largest producer of vaccines by volume, can ship out the Astra vaccine priced between $5-10 per dose

India to start Covid-19 vaccine exports on Wednesday, says report

The foreign ministry said shipments would start on Wednesday following requests from "neighbouring and key partner countries"

Nasal vaccine: Bharat Bio told to submit efficacy data from Phase-3 trials

India may start vaccine exports as soon as today

Glitches in Co-WIN are minor, new system to work like RAC: R S Sharma

R S Sharma, who chairs the empowered committee on technology for Covid vaccine, spoke to Nivedita Mookerji on what went wrong with Co-Win during the first few days, the scale-up exercise, and more

Expert panel recommends phase 1 trial of Bharat Biotech's nasal vaccine

A top government official said that if this vaccine works it can be a game changer in the fight against COVID-19

Deplorable to overreact, entice fear without due diligence on vax: Vardhan

The health minister also referred to an earlier tweet by him on January 15, wherein he had posted a chart with details of all those people who should not get the vaccine Read more at: https://www.dec

Centre issues Letter of Comfort to Bharat Biotech for 4.5 mn Covaxin doses

. Bharat Biotech said it has also donated 16.5 lakh doses to the Government of India. Sources further said the supplies from the company depend on the orders being placed by the government

Bharat Biotech asks people with fever, pregnant women to avoid Covaxin

The vaccine maker in the fact sheet on Covaxin, posted in its website, said the clinical efficacy of the vaccine is yet to be established and is being studied in Phase 3 clinical trial

380,000 vaccinated so far, no serious adverse events, says health ministry

Two deaths were reported in Uttar Pradesh and Karnataka, one not linked to jab, the other yet to be investigated

Vaccination in Delhi: Further slump in turnout, only 8 get jabs at AIIMS

Nearly 3,600 healthcare workers received the COVID-19 vaccine shots in Delhi on Monday, a further dip in the figures compared to that on the opening day of the immunisation drive